{"transactions":[{"id":1425901,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-08-22T22:02:33.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":155000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 20, 2024, February 20, 2025, May 20, 2025, and August 20, 2025."}],"balance_after":155000,"derivative":{"exercise_price":0.07,"expiration_date":"2034-08-20","underlying":"Common Stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001493152-24-033621","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000149315224033621/ownership.xml","form_type":"4"}},{"id":1816967,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-08-03T20:17:13.000Z","date":"2023-08-01","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on November 1, 2023, February 1, 2024, May 1, 2024, and August 1, 2024."}],"balance_after":150000,"derivative":{"exercise_price":0.12,"expiration_date":"2033-08-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-044423","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919123044423/doc4.xml","form_type":"4"}},{"id":2145777,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-04T20:48:10.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments December 30, 2022, March 30, 2023, June 30, 2023, and September 30, 2023."}],"balance_after":100000,"derivative":{"exercise_price":0.2,"expiration_date":"2032-09-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-22-052321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919122052321/doc4.xml","form_type":"4"}},{"id":2659471,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-23T00:17:15.000Z","date":"2021-06-18","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022."}],"balance_after":100000,"derivative":{"exercise_price":0.45,"expiration_date":"2031-06-18","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001209191-21-042591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919121042591/doc4.xml","form_type":"4"}},{"id":3143667,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-05-19T22:52:14.000Z","date":"2020-05-15","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on August 15, 2020, November 15, 2020, February 15, 2021 and May 15, 2021."}],"balance_after":150000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-05-15","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-030695","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120030695/doc4.xml","form_type":"4"}},{"id":3297037,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-01T01:39:40.000Z","date":"2020-01-29","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in eight equal quarterly installments beginning on April 30, 2020."}],"balance_after":150000,"derivative":{"exercise_price":0.33,"expiration_date":"2030-01-29","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-20-005910","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919120005910/doc4.xml","form_type":"4"}},{"id":4028289,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-03-01T00:13:10.000Z","date":"2018-02-26","kind":"grant","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option.  The option was originally granted on May 11, 2016 with an exercise period of 2 years.  The term of the option has been amended to extend the exercise period to five years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016."}],"balance_after":150000,"derivative":{"exercise_price":1.15,"expiration_date":"2021-05-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-014690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118014690/doc4.xml","form_type":"4"}},{"id":4028288,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-03-01T00:13:10.000Z","date":"2018-02-26","kind":"disposition_to_issuer","acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The two reported transactions involve an amendment of an outstanding option, resulting in the deemed cancellation of the \"old\" option and the grant of a replacement option.  The option was originally granted on May 11, 2016 with an exercise period of 2 years.  The term of the option has been amended to extend the exercise period to five years from the date of grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on August 11, 2016."}],"balance_after":0,"derivative":{"exercise_price":1.15,"expiration_date":"2018-05-11","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-014690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118014690/doc4.xml","form_type":"4"}},{"id":4028287,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-03-01T00:13:10.000Z","date":"2018-02-26","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the option shares shall vest and become exercisable in four equal quarterly installments beginning on May 26, 2018."}],"balance_after":150000,"derivative":{"exercise_price":0.78,"expiration_date":"2023-02-26","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-014690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919118014690/doc4.xml","form_type":"4"}},{"id":4405892,"issuer":{"id":7969,"kind":"organization","name":"PURE BIOSCIENCE, INC."},"owners":[{"id":88093,"kind":"person","name":"Elliott Mark Stuart","position":1,"cik":"0001649406","reported_name":"Elliott Mark Stuart","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Vice President, Finance"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-03-03T23:23:00.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shares shall vest and become exercisable in four equal installments on April 30, 2017, July 31, 2017, October 31, 2017 and January 31, 2018."}],"balance_after":150000,"derivative":{"exercise_price":0.88,"expiration_date":"2022-03-01","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-17-017980","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1006028/000120919117017980/doc4.xml","form_type":"4"}}]}